Evidence map›Paper›PMID 40785832›Full record

ReviewClinical, cosmetic and investigational dermatology2025

Dermatofibroma: Reappraisal and Updated Review.

Leo Wan, Aileen Park, Lanah Almatroud, Amor Khachemoune

Abstract readReview
In one paragraph

Review in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leo Wan *Department of Medicine, West Virginia School of Osteopathic Medicine, Lewisburg, WV, USA.ORCID 0000-0003-2485-4708
Aileen Park *Department of Medicine, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.ORCID 0000-0003-0073-1981
Lanah Almatroud *Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.ORCID 0009-0006-6679-2591
Amor KhachemounePremier Dermatology, Ashburn, VA, USA.ORCID 0000-0003-1622-1097

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatofibromas (DF), also known as fibrous histiocytomas, are common benign cutaneous lesions characterized histologically by dermal proliferation of spindle-shaped fibrocytes, with the overlying epidermis often demonstrating hyperplasia with acanthosis, basal layer hyperpigmentation, and a characteristic "collarette" of epidermal hyperplasia surrounding the lesion. The etiology of DF remains debated, with theories ranging from reactive processes triggered by local trauma, such as insect bites, to spontaneous development. DF typically presents as a hyperkeratotic nodule or plaque, most often on the lower extremities, and can exhibit a wide spectrum of clinical appearances. Variants such as hemosiderotic, epithelioid, aneurysmal, and cellular DF show distinct clinical and histopathological features that may sometimes mimic malignant lesions. Dermoscopic findings can aid in diagnosis, although biopsy is often required for definitive classification. Discrepancies in the literature persist regarding the pathogenesis and classification of DF, and while DF is generally benign, rare cases of metastasizing DF have been reported. This review aims to provide an examination of DF, including its clinical manifestations, etiology, subtypes, histological features, and differential diagnoses. It also discusses dermoscopic findings, controversies in the literature, and current treatment options. A clearer understanding of its diverse presentations, along with refined diagnostic criteria, will enhance clinical management and treatment strategies.

Indexed as

cutaneous lesionsdermoscopyhistiocytomasubtypes

Identifiers

PMID40785832
PMCPMC12333637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.